Teva $35M Delayed Generic Inhalers Deal Gets Initial OK
A Massachusetts federal judge Thursday granted initial approval to a $35 million deal that Teva Pharmaceuticals agreed to pay to resolve claims from a coalition of union healthcare funds that say...To view the full article, register now.
Already a subscriber? Click here to view full article